Global Capecitabine Market to Witness High Single-Digit CAGR over Forecast Period during 2018-2025

Posted on 2018-10-11 by Mark Hub in Healthcare, Industrial, Pharmaceuticals // 0 Comments

Albany, US, 2018-Oct-11 — /EPR Network/ —Market Research Hub (MRH) has actively included a new research study titled “Global Capecitabine Market Insights, Forecast to 2025” to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period until 2025. In addition, a deep analysis of the competitive landscape, including prime market players is also enclosed in this report.

Request for free Sample @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=1915983

This report studies the global market size of Capecitabine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Capecitabine in these regions.

This research report categorizes the global Capecitabine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
Capecitabine is a prescription medication used to treat breast cancer and cancer of the colon or rectum. Capecitabine belongs to a group of drugs called antimetabolites which work by interfering with DNA production, stopping cells from multiplying. The medication comes in tablet form and is usually taken twice daily, within 30 minutes after the end of a meal. The proportion of breast cancer with Handle in 2016 is about 40%, and the proportion of colorectal cancer in 2016 is about 31.94%.
Cancer clinical treatment projects have led to the increasing demand for Capecitabine. Increasing Cancer incidence across the globe, especially in the Asia-Pacific is another major factor, driving the growth of the Capecitabine market during the forecast period.
In 2017, the global Capecitabine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Capecitabine market based on company, product type, application and key regions.

The various contributors involved in the value chain of Capecitabine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Capecitabine include
Roche
Teva
Mylan
Hikma
Hengrui Medicine
Cipla
Reliance Group
Hetero

Market Size Split by Type
500 mg
150 mg
Market Size Split by Application
Breast Cancer
Colorectal Cancer
Stomach Cancer

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Capecitabine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Capecitabine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Capecitabine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Capecitabine with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Capecitabine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Capecitabine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (Kg). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Capecitabine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

Browse Full Report with TOC@ https://www.marketresearchhub.com/report/global-capecitabine-market-insights-forecast-to-2025-report.html

Table of Contents

1 Study Coverage
1.1 Capecitabine Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Capecitabine Market Size Growth Rate by Type
1.4.2 500 mg
1.4.3 150 mg
1.5 Market by Application
1.5.1 Global Capecitabine Market Size Growth Rate by Application
1.5.2 Breast Cancer
1.5.3 Colorectal Cancer
1.5.4 Stomach Cancer
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Capecitabine Market Size
2.1.1 Global Capecitabine Revenue 2016-2025
2.1.2 Global Capecitabine Sales 2016-2025
2.2 Capecitabine Growth Rate by Regions
2.2.1 Global Capecitabine Sales by Regions
2.2.2 Global Capecitabine Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Capecitabine Sales by Manufacturers
3.1.1 Capecitabine Sales by Manufacturers
3.1.2 Capecitabine Sales Market Share by Manufacturers
3.1.3 Global Capecitabine Market Concentration Ratio (CR5 and HHI)
3.2 Capecitabine Revenue by Manufacturers
3.2.1 Capecitabine Revenue by Manufacturers (2016-2018)
3.2.2 Capecitabine Revenue Share by Manufacturers (2016-2018)
3.3 Capecitabine Price by Manufacturers
3.4 Capecitabine Manufacturing Base Distribution, Product Types
3.4.1 Capecitabine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Capecitabine Product Category
3.4.3 Date of International Manufacturers Enter into Capecitabine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

Continue…@@$

Enquire about this Report – https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1915983

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of pharma market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick